Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 13
Plaintiff Says New Class Action Law Doesn't Apply to Celebrex Case
Second California Vioxx Judge Replaced Following Merck Peremptory Challenge
HMO Sues Merck over Past and Future Payment for Vioxx-Related Injuries
New Jersey Judge Dismisses Vioxx Medical Monitoring Claim With Prejudice
New Judge Takes Over California Vioxx Docket, Says She May Have Taken Vioxx
Parties Submit Briefs on Ex Parte Communications with Plaintiffs' Physicians
Texas Vioxx Trial Set for July 11; Merck Moves to Quash Deposition
Arthritis Drugs - Issue: 12
Journal Watch, Litigation Watch-Arthritis Drugs, May 2005
